NCT02488044 - A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions

Arginase I DeficiencyHyperargininemia

Interventions

DRUG

AEB1102

modified human arginase I

Trial Locations (9)

Icahn School of Medicine at Mount Sinai, New York

University of Florida, Gainesville

Children's Hospital of Michigan, Detroit

UTSW, Dallas

Stanford University School of Medicine, Stanford

Seattle Children's Hospital, Seattle

The Hospital for Sick Children, Toronto

Centro Hospitalar S. Joao, Porto

Great Ormond Street Hospital, London